Initial anticoagulant therapy with fondaparinux in a patient with not massive residual pulmonary embolism in conditions of city general hospital

В статье представлены результаты сравнительного анализа 50 больных тромбоэмболии легочной артерии (ТЭЛА), которые по способу лечения были разделены на 3 группы: I группа - с антикоагулянтной терапией (гепарин). II группа - с селективной катетерной тромболитической (альтеплаза) и антикоагулянтной терапией. III группа - с катетерной аспирационной тромбоэкстракцией; Установлено, что на фоне комплексной терапии, включающую тромболитическую и антикоагулянтную терапии наблюдалась лучшая выживаемость пациентов с острой ТЭЛА. The article presents results of a comparative analysis of 50 patients with pulmonary embolism (PE), which were divided into 3 groups according to the method of treatment: Group I - with anticoagulant therapy (heparin); Group II - with catheter thrombolytic (alteplase) and anticoagulant therapy. Group III - with catheter embolectomy (aspiration thromboextraction); It was found against the background of complex therapy, including thrombolytic and anticoagulant therapy, there was a better survival rate for patients with acute PE.

Download Full-text

A Critical Evaluation of Anticoagulant Therapy in Peripheral Venous Thrombosis and Pulmonary Embolism

Plastic & Reconstructive Surgery ◽

10.1097/00006534-195805000-00027 ◽

1958 ◽

Vol 21 (5) ◽

pp. 415-416

Author(s):

W W Coon ◽

J W Mackenzie ◽

P E Hodgson

Keyword(s):

Pulmonary Embolism ◽

Venous Thrombosis ◽

Anticoagulant Therapy ◽

Critical Evaluation

Download Full-text

Comparison of 3 and 6 Months of Oral Anticoagulant Therapy After a First Episode of Proximal Deep Vein Thrombosis or Pulmonary Embolism and Comparison of 6 and 12 Weeks of Therapy After Isolated Calf Deep Vein Thrombosis

Circulation ◽

10.1161/01.cir.103.20.2453 ◽

2001 ◽

Vol 103 (20) ◽

pp. 2453-2460 ◽

Cited By ~ 255

Author(s):

Laurent Pinede ◽

Jacques Ninet ◽

Pierre Duhaut ◽

Sylvie Chabaud ◽

Sylvie Demolombe-Rague ◽

...

Keyword(s):

Pulmonary Embolism ◽

Deep Vein Thrombosis ◽

Anticoagulant Therapy ◽

Oral Anticoagulant ◽

Oral Anticoagulant Therapy ◽

Proximal Deep Vein Thrombosis ◽

First Episode ◽

Vein Thrombosis ◽

Deep Vein

Download Full-text

Renal Vein Thrombosis and Pulmonary Embolism Secondary to Vaccine-induced Thrombotic Thrombocytopenia (VITT)

European Journal of Case Reports in Internal Medicine ◽

10.12890/2021_002692 ◽

2021 ◽

Author(s):

Nikita Cliff-Patel ◽

Lindsay Moncrieff ◽

Veqas Ziauddin

Keyword(s):

Pulmonary Embolism ◽

General Hospital ◽

Regulatory Agency ◽

Renal Vein ◽

District General Hospital ◽

Renal Vein Thrombosis ◽

The Other ◽

Pulmonary Emboli ◽

Vein Thrombosis ◽

The Uk

The Medicines and Healthcare products Regulatory Agency (MHRA) of the UK has approved the use of three vaccines to combat COVID-19 (SARS-CoV-2). There have been rare reports of thrombosis after vaccination with the AstraZeneca vaccine. We present three cases of vaccine-induced thrombotic thrombocytopenia (VITT) in one UK district general hospital following administration of this vaccine. Two of the patients had asymptomatic pulmonary emboli, while the other is the first known case of both renal vein thrombosis and pulmonary embolism.

Download Full-text